We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Raffles to Launch Second Hospital Project in China

By HospiMedica International staff writers
Posted on 09 May 2017
Print article
Image: An artist’s impression of Raffles Hospital Chongqing (Photo courtesy of Raffles Medical Group).
Image: An artist’s impression of Raffles Hospital Chongqing (Photo courtesy of Raffles Medical Group).
Raffles Medical Group, one of the leading integrated healthcare organizations in Asia, has announced that it is developing its second international tertiary hospital in Chongqing (China).

When completed, the international Raffles Hospital Chongqing will be able to serve local and expatriate patients in the western part of China, as well as foreign patients from Central Asian republics. The new 700-bed capacity hospital and the soon to be completed 400-bed capacity Raffles Hospital Shanghai are expected to start operations at the end of 2018 with 200 private beds each. Raffles Medical clinics in Chongqing, Shanghai, Beijing, Nanjing, Tianjin, Dalian, and Shenzhen, which have access to the Raffles Medical network, will feed into the two new China hospitals.

Raffles Medical Group, which is based in Singapore, currently operates in 13 cities across Asia, and has announced plans for two new hospitals in Beijing and Shenzhen, and is considering a third. The medical group currently holds representative offices in Indonesia, Vietnam, Cambodia, Brunei, Bangladesh, and the Russian Far East, as well as business associates throughout the Asia Pacific region.

“We have done our market survey, and found that the top 10% of 33 million people in Chongqing can afford internationally priced health care,” said Loo Choon Yong, MD, executive chairman of Raffles Medical Group. “Together with the upcoming Shanghai hospital, we will be a major player in tertiary hospital services in China, where there is significant demand for good quality healthcare from locals and foreigners.”

The State Council of the People’s Republic of China (Beijing; www.gov.cn) announced in June 2015 that it will reduce bureaucratic red-tape for new facilities. Among other measures, private-capital-invested hospitals will be integrated into the medical insurance system, a move designed to encourage the development of new medical institutions. The State Council also stipulated that public health insurance will extend healthcare coverage to qualified private facilities, and will not be able to reject them for reasons other than their medical service abilities.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Semi-Automatic Mobile Cushion System
CariChair
New
Endocavity Needle Guide
Vitro PRO

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.